Depth perception affected by COVID virus Emerging Viruses, Inflammation and Therapeutics PublishedDecember 15, 2022 AuthorChristine Bowley Researchers are investigating whether the COVID virus can affect vision and depth-perception of those infected.
Griffith awarded more than $4 million in NHMRC Investigator Fellowships Griffith Health PublishedOctober 14, 2022October 17, 2022 AuthorCarley Rosengreen We are delighted to share some successful outcomes for NHMRC Investigator Fellowships announced on 12 October 2022 by the National Health and Medical Research Council (NHMRC).
World first chronic fatigue syndrome findings could fast track response to Long COVID COVID-19 PublishedAugust 11, 2022September 7, 2022 AuthorEmma O'Connor Study suggests COVID-19 could be a potential trigger for ME/CFS.
Delta’s sneaky trick to evade the body’s immune response Griffith Health PublishedApril 20, 2022August 25, 2022 AuthorContributed COVID-19's Delta strain may use a novel invasion method to cause more damage to the brain, intestine and kidneys.
Studies reveal new mechanisms of arthritis caused by mosquito-borne viruses Griffith Health PublishedMarch 9, 2022March 9, 2023 AuthorContributed Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.
Exercise trial aims to help women with recurrent ovarian cancer Griffith Health PublishedFebruary 24, 2022March 9, 2023 AuthorContributed Griffith University researchers are conducting a world-leading trial assessing the role of exercise as therapy for women with recurrent ovarian cancer
Bacteria in the nose may increase risk of Alzheimer’s disease Griffith Institute for Drug Discovery (GRIDD) PublishedFebruary 18, 2022March 9, 2023 AuthorContributed A bacterium commonly present in the nose can sneak into the brain and may increase the risk of Alzheimer’s disease.